MedDataX Logo

Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients

NCT ID: NCT01025024

Last Updated: 2009-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1224 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-31

Study Completion Date

2009-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A single-nucleotide polymorphism (SNP) analysis of DNA obtained from peripheral blood of the glaucoma patients and the normal control will be performed to find genetic marker for primary open angle glaucoma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Unrelated Korean subjects who have primary open angle glaucoma were recruited in the current study. Genotyping for various SNP associated with POAG due to the linkage disequilibrium patterns is to be performed. Genotypes would be statistically compared between patients with primary open angle glaucoma and normal control subjects free of any eye diseases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Single-nucleotide Polymorphism (SNP) for Glaucoma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

SNP single-nucleotide polymorphism glaucoma primary open angle glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

POAG group

Elevated intraocular pressure normal open angle glaucomatous optic nerve head abnormality glaucomatous visual field defect

SNP analysis of the DNA

Intervention Type GENETIC

SNP analysis of the DNA obtained from peripheral blood sample

Normal control

Normal intraocular pressure No optic disc abnormality No visual field defect No significant ocular and systemic disease

SNP analysis of the DNA

Intervention Type GENETIC

SNP analysis of the DNA obtained from peripheral blood sample

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SNP analysis of the DNA

SNP analysis of the DNA obtained from peripheral blood sample

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of primary open angle glaucoma

Exclusion Criteria

* Primary open angle glaucoma combined with congenital ocular disease
* Primary open angel glaucoma combined with other ocular disease
* Significant systemic disease other than systemic hypertension and diabetes
Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Korea Healthcare Technology R&D Project

UNKNOWN

Sponsor Role collaborator

Korea Advanced Institute of Science and Technology

OTHER

Sponsor Role collaborator

Chungnam National University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Ophthalmology, College of Medicine, Chungnam National University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chang-sik Kim, professor

Role: PRINCIPAL_INVESTIGATOR

Department of Ophthalmology, Chungnam National University Hospital

Changwon Kang, professor

Role: STUDY_CHAIR

Korea Advanced Institute of Science and Technology

Kyunglan Kim

Role: STUDY_DIRECTOR

Department of Biological Sciences, Korea Advanced Institute of Science and Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chungnam National University Hospital

Daejeon, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A080587

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

CNUH81510-886

Identifier Type: -

Identifier Source: org_study_id